Can a Parent-Targeted program ease Kids' behavior problems when depression is in the picture?

NCT ID NCT07749521

First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This trial compares two parenting programs for caregivers who have depression and are seeking help for their child's emotional or behavioral difficulties. The experimental program, ADAPT, is designed to address the unique emotional needs of depressed parents, while the control is the standard Incredible Years program. Researchers will measure changes in child behavior, parental depression, and quality of life before, right after, and six months after treatment. The goal is to see if a tailored approach can improve outcomes for both parents and children.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
ADAPT, a 10-session virtual caregiver program combining individual and group sessions focused on emotion regulation, distress tolerance, and cognitive restructuring
What this could lead to
If ADAPT works, it could offer a more effective parenting program for depressed parents, improving both child behavior and parental well-being.
What could go wrong
This is a relatively small trial, and the benefits may not be large or lasting. The program is virtual, which may not suit everyone, and results may not generalize beyond the study setting.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONDUCT DISORDERS IN CHILDREN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ontario Institute for Studies in Education (OISE)

    RECRUITING

    Toronto, Ontario, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.